Skip to main content

WPI 1.5 Pill - beige round, 8mm

Pill with imprint WPI 1.5 is Beige, Round and has been identified as Paliperidone Extended-Release 1.5 mg. It is supplied by Actavis Pharma, Inc.

Paliperidone is used in the treatment of Schizoaffective Disorder; Schizophrenia and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Paliperidone 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 1.5

Paliperidone extended-release 1.5 mg WPI 1.5
Paliperidone extended-release 1.5 mg WPI 1.5 Front
Paliperidone extended-release 1.5 mg WPI 1.5 Back

Paliperidone Extended-Release

WPI 1.5
1.5 mg
8.00 mm
Prescription only
Drug Class
Atypical antipsychotics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
Inactive Ingredients
ammonia, butylated hydroxytoluene, cellulose acetate, silicon dioxide, FD&C Red No. 40, aluminum oxide, hydroxypropyl cellulose, hypromelloses, ferrosoferric oxide, polyethylene glycol, povidone, propylene glycol, sodium chloride, stearic acid, titanium dioxide, ferric oxide yellow, ferric oxide red, magnesium silicate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "WPI 1.5"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.